A clinical study to see the effect of some Ayurvedic formulation in the form of nasal administration in the treatment of Vataj Shirashoola w.r.t. Headache

Comparative clinical trial to evaluate the efficacy of Baladi Ghritamanda Nasya and Ksheerabala Taila Nasya in the Management of Vataj Shirashoola

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031146

Enrollment

Registered

2021-02-09

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R51- Headache Health Condition 2: R51- Headache

Interventions

Intervention1: Baladi Ghritamanda: It is a formulation of Ayurvedic herbs prepared in the form of ghritamanda for nasal administration(nasya) having Bala and Bilva churna,Goghrita,Ghritamanda ,godugdh

Eligibility

Inclusion criteria

Inclusion criteria: 1)patients suffering from symptoms of Vataj Shiashoola i.e. Shankha Ativedana, Bhru Ativedana, Lalat Ativedana 2)patients of age group 20 to 60 yrs 3)patients of eiter gender will be included in the study 4)patients yogya for Nasyakarma

Exclusion criteria

Exclusion criteria: 1)patients suffering from Sinusitis,systemic disorder like Hypertension, Diabetes, 2)Secondary Headache caused by Meningitis, Tumour, Encephalitis 3)Pregnancy and Lactation

Design outcomes

Primary

Measure	Time frame
A clinical study to evaluate efficacy of Baladi Ghritamanda Nasya in Vataj Shirashoola w.r.t. Headache. Subjective Parameters(by using grades and Visual analogue Scale)-Shankha Ativedana,Bhru Ativedana,Lalat Ativedana Other subjective parameters-Severity of headache, Frequency of headache,Duration of headacheTimepoint: The drug will be given for 7 days.patient will be assessed before and after treatment.Total duration of study will be 18 months.	—

Measure

Time frame

A clinical study to evaluate efficacy of Baladi Ghritamanda Nasya in Vataj Shirashoola w.r.t. Headache. Subjective Parameters(by using grades and Visual analogue Scale)-Shankha Ativedana,Bhru Ativedana,Lalat Ativedana Other subjective parameters-Severity of headache, Frequency of headache,Duration of headacheTimepoint: The drug will be given for 7 days.patient will be assessed before and after treatment.Total duration of study will be 18 months.

—

Secondary

Measure	Time frame
Comparision between efficacy of Baladi Ghritamanda Nasya and Ksheerabala Taila Nasya in Vataj Shirashoola w.r.t. Headahe.Timepoint: Total duration of study will be 18 months	—

Countries

India

Contacts

Public ContactVd Mahejabeen Munir Jikare

Sumatibhai Shah Ayurved Mahavidyalaya

drnspradhan@yahoo.com9423580963

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026